Balance Sheet
Accounts PayablesAccumulated ExpensesAssetsCash & Current InvestmentsCash & EquivalentsCommon EquityCurrent AssetsCurrent Deferred RevenueCurrent LeasesFinished GoodsGoodwillGoodwill & IntangiblesIntangiblesInventoryLiabilities and Shareholders EquityNon-Current AssetsNon-Current DebtNon-Current Deffered RevenueNotes PayablesOperating LeasesOther Accumulated ExpensesOther Non-Current AssetsOther Non-Current LiabilitiesPayablesPreferred Stock LiabilitiesPrepaid AssetsProperty, Plant & Equipment (Net)Property, Plant & Equipment (Net)Raw MaterialsReceivablesReceivables - NetRetained EarningsShareholder's EquityShares OutstandingShort term DebtTotal Current LiabilitiesTotal DebtTotal LiabilitiesTotal Non-Current LiabilitiesTreasury SharesWork In Process
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Ekso Bionics Holdings (EKSO) Retained Earnings (2016 - 2026)

Ekso Bionics Holdings has reported Retained Earnings over the past 14 years, most recently at -$692000.0 for Q4 2025.

  • On a quarterly basis, Retained Earnings fell 172.31% to -$692000.0 in Q4 2025 year-over-year; TTM through Dec 2025 was -$692000.0, a 172.31% decrease, with the full-year FY2025 number at -$692000.0, down 172.31% from a year prior.
  • Retained Earnings reached -$692000.0 in Q4 2025 per EKSO's latest filing, up from -$700000.0 in the prior quarter.
  • The five-year high for Retained Earnings was $957000.0 in Q4 2024, with the low at -$253.6 million in Q1 2025.
  • The 5-year median for Retained Earnings is -$204.4 million (2021), against an average of -$124.9 million.
  • Peak YoY movement for Retained Earnings: crashed 1317235.29% in 2022, then skyrocketed 100.4% in 2024.
  • Tracing EKSO's Retained Earnings over 5 years: stood at -$17000.0 in 2021, then crashed by 1317235.29% to -$223.9 million in 2022, then dropped by 6.79% to -$239.1 million in 2023, then soared by 100.4% to $957000.0 in 2024, then crashed by 172.31% to -$692000.0 in 2025.
  • According to Business Quant data, Retained Earnings over the past three periods came in at -$692000.0, -$700000.0, and -$683000.0 for Q4 2025, Q3 2025, and Q2 2025 respectively.